Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
RHC trades on 21x forward earnings, dividend yield of 2.4% and underlying EPS growth into FY20 of 2 – 4 %. Forecast FY20 revenue $13bn, EBIT $1.2bn, EPS $3.00 & DPS $1.55.
In a low rate environment, we see the new trading range for Ramsay within the $65 – $70 band.
We see buying support building at the $64 price level.